Highlights
- •The inaccuracy of calculated low-density lipoprotein cholesterol is well known.
- •Evidence that low levels of low-density lipoprotein cholesterol directly result in adverse events is lacking.
- •Individuals with heterozygous apolipoprotein B–related familial hypobetalipoproteinemia are at risk of fatty liver disease.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical LipidologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN).J Pediatr Gastroenterol Nutr. 2017; 64: 319-334
- Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.J Clin Lipidol. 2015; 9: 576-582
- Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.Pediatrics. 2011; 128: S213-S256
- Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the third national health and nutrition examination survey.Prev Med. 1998; 27: 879-890
- Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.Nat Genet. 2005; 37: 161-165
- Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy.Arterioscler Thromb Vasc Biol. 2006; 26: 1094-1100
- Molecular diagnosis of hypobetalipoproteinemia: an ENID review.Atherosclerosis. 2007; 195: e19-e27
- Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.J Biol Chem. 2007; 282: 24270-24283
- Recent developments in the genetics of LDL deficiency.Curr Opin Lipidol. 2013; 24: 111-115
- Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia.Arterioscler Thromb Vasc Biol. 2005; 25: 1979-1984
- Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.J Lipid Res. 2004; 45: 941-947
- Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population.Arterioscler Thromb Vasc Biol. 1998; 18: 1745-1751
- Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clin Chem. 1972; 18: 499-502
- Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.Clin Chem. 2002; 48: 236-254
- A test in context: lipid profile, fasting versus nonfasting.J Am Coll Cardiol. 2017; 70: 1637-1646
- Comparison of low-density lipoprotein cholesterol assessment by martin/hopkins estimation, friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER trial.JAMA Cardiol. 2018; 3: 749-753
- Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.J Clin Lipidol. 2017; 11: 1065-1072
- Update on the laboratory investigation of dyslipidemias.Clin Chim Acta. 2018; 479: 103-125
- Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.Clin Chem. 2011; 57: 490-501
- Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.Clin Chem. 2009; 55: 888-894
- Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol.Clin Biochem. 2014; 47: 1098-1099
- Can LDL cholesterol be too low? Possible risks of extremely low levels.J Intern Med. 2017; 281: 534-553
- LDL cholesterol: how low to go?.Trends Cardiovasc Med. 2017; 28: 348-354
- Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Serum lipids and lipoproteins.Pediatrics. 1987; 80: 789-796
- A receptor-mediated pathway for cholesterol homeostasis.Science. 1986; 232: 34-47
- Cholesterol: its regulation and role in central nervous system disorders.Cholesterol. 2012; 2012: 19
- Cholesterol metabolism and homeostasis in the brain.Protein Cell. 2015; 6: 254-264
- Effect of very low LDL-cholesterol on cortisol synthesis.J Endocrinol Invest. 2008; 31: 1075-1078
- Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.N Engl J Med. 2006; 354: 1264-1272
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.Nat Genet. 2008; 40: 189-197
- The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic.Eur J Clin Nutr. 2002; 56: S42-S52
- Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer.Mayo Clin Proc. 2004; 79: 101-108
- Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.J Lipid Res. 2003; 44: 470-478
- Alirocumab and cardiovascular outcomes after acute coronary syndrome.N Engl J Med. 2018; 379: 2097-2107
- Recent advances in the pharmacological management of hypercholesterolaemia.Lancet Diabetes Endocrinol. 2016; 4: 436-446
- Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.J Clin Endocrinol Metab. 2007; 92: 1474-1478
- Nonalcoholic steatohepatitis: an expanded clinical entity.Gastroenterology. 1994; 107: 1103-1109
- Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes.J Lipid Res. 1996; 37: 844-852
- Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele.J Lipid Res. 2004; 45: 155-163
- Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.Gastroenterology. 2010; 139: 149-153
- Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease.Sci Rep. 2019; 9: 3682
- Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.J Inherit Metab Dis. 2014; 37: 333-339
- Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.Dig Dis Sci. 1998; 43: 2489-2492
- The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.Hepatology. 1990; 11: 74-80
- Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia.Mol Genet Metab. 2009; 96: 66-72
- Organ loci of catabolism of short truncations of apoB.Arterioscler Thromb Vasc Biol. 1997; 17: 1032-1038
- Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.Adv Clin Chem. 2011; 54: 81-107
- Rare protein-truncating variants in APOB, lower LDL-C, and protection against coronary heart disease.Circ Genom Precis Med. 2019; ([e-pub ahead of print])https://doi.org/10.1161/CIRCGEN.118.002376
- Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?.Intern Emerg Med. 2009; 4: 71-73
Article info
Publication history
Published online: May 16, 2019
Identification
Copyright
© 2019 National Lipid Association. All rights reserved.
